Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning.

Strohm, Claudia

Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning. [electronic resource] - Cardiovascular research Aug 2002 - 602-18 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0008-6363

10.1016/s0008-6363(02)00453-4 doi


Activating Transcription Factor 2
Analysis of Variance
Animals
Butadienes--pharmacology
Cyclic AMP Response Element-Binding Protein--genetics
DNA-Binding Proteins
Dactinomycin--pharmacology
Dose-Response Relationship, Drug
Enzyme Activation--drug effects
Enzyme Inhibitors--pharmacology
Immunoblotting
Ischemic Preconditioning, Myocardial--methods
Male
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Myocardial Infarction--metabolism
Myocardium--metabolism
Nitriles--pharmacology
Nucleic Acid Synthesis Inhibitors--pharmacology
Proto-Oncogene Proteins--genetics
Proto-Oncogene Proteins c-fos
Proto-Oncogene Proteins c-jun
Proto-Oncogene Proteins c-myc
RNA, Messenger--analysis
Swine
Transcription Factors--genetics
ets-Domain Protein Elk-1